群馬大学神経科学グループ 脳研究統合フォーラム
  • 文字サイズ
  • 小
  • 中
  • 大
アクセス・お問合せ

業績集

サブメニューを開く


Warning: Undefined variable $post in /home/.sites/31/site63/web/wp-content/themes/brain-smph/functions.php on line 312

Warning: Attempt to read property "post_parent" on null in /home/.sites/31/site63/web/wp-content/themes/brain-smph/functions.php on line 312
医学系研究科・高次機能統御系

脳神経再生医学分野

  1. Nóbrega C, Nascimento-Ferreira I, Onofre I, Albuquerque D, Hirai H, Déglon N, de Almeida LP.
    Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice.
    PLoS One 2013;8(1):e52396. (IF: 4.092)
  2. Takechi Y, Mieda T, Iizuka A, Toya S, Suto N, Takagishi K, Nakazato Y, Nakamura K, Hirai H.
    Impairment of spinal motor neurons in spinocerebellar ataxia type 1-knock-in mice.
    Neuroscience Letters 2013 Feb 22;535:67-72. (IF: 2.105)
  3. Yamaura H, Hirai H, Yanagihara D.
    Postural dysfunction in a transgenic mouse model of spinocerebellar ataxia type 3.
    Neuroscience 2013 Jul 23;243:126-35. (IF: 3.292)
  4. Mikuni T, Uesaka N, Okuno H, Hirai H, Deisseroth K, Bito H, Kano M.

    Arc/Arg3.1 is a postsynaptic mediator of activity-dependent synapse elimination in the developing cerebellum.
    Neuron 2013 Jun 19;78(6):1024-35. (IF: 15.766)

  5. Nascimento-Ferreira I, Nóbrega C, Vasconcelos-Ferreira A, Onofre I, Albuquerque D, Aveleira C, Hirai H, Déglon N, Pereira de Almeida L.
    Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease.
    Brain 2013 Jul;136(Pt 7):2173-88. (IF: 9.915)
  6. Miki T, Hirai H, Takahashi T.
    Activity-dependent neurotrophin signaling underlies developmental switch of Ca2+ channel subtypes mediating neurotransmitter release.
    Journal of Neuroscience 2013 Nov 27;33(48):18755-63. (IF: 6.908)
  7. Liu HX, Lopatina O, Higashida C, Fujimoto H, Akther S, Inzhutova A, Liang M, Zhong J, Tsuji T, Yoshihara T, Sumi K, Ishiyama M, Ma WJ, Ozaki M, Yagitani S, Yokoyama S, Mukaida N, Sakurai T, Hori O, Yoshioka K, Hirao A, Kato Y, Ishihara K, Kato I, Okamoto H, Cherepanov SM, Salmina AB, Hirai H, Asano M, Brown DA, Nagano I, Higashida H.
    Displays of paternal mouse pup retrieval following communicative interaction with maternal mates
    Nature Communications 2013;4:1346 (IF: 10.015)
  8. Akther S, Korshnova N, Zhong J, Liang M, Cherepanov SM, Lopatina O, Komleva YK, Salmina AB, Nishimura T, Fakhrul AA, Hirai H, Kato I, Yamamoto Y, Takasawa S, Okamoto H, Higashida H.
    CD38 in the nucleus accumbens and oxytocin are related to paternal behavior in mice.
    Molecular Brain 2013 Sep 23;6(1):41. (IF: 4.202)

  9. Irie T, Matsuzaki Y, Sekino Y, Hirai H.
    Kv3.3 channels harboring a mutation of spinocerebellar ataxia type 13 alterexcitability and induce cell death in cultured cerebellar Purkinje cells.
    Journal of Physiology 2014 Jan 1;592(Pt 1):229-47. (IF: 4.38)

  10. Konno A, Shuvaev AN, Miyake N, Miyake K, Iizuka A, Matsuura S, Huda F, Nakamura K, Yanagi S, Shimada T, Hirai H.
    Mutant Ataxin-3 with an Abnormally Expanded Polyglutamine Chain Disrupts Dendritic Development and Metabotropic Glutamate Receptor Signaling in Mouse Cerebellar Purkinje Cells.
    Cerebellum 2014 Feb;13(1):29-41. (IF: 2.595)

  11. Matsuzaki Y, Oue M, Hirai H.
    Generation of a neurodegenerative disease mouse model using lentiviral vectors carrying an enhanced synapsin I promoter.
    Journal of Neuroscience Methods 2014 Feb 15;223:133-43. (IF: 2.114)

  12. Matsuura S, Shuvaev AN, Iizuka A, Nakamura K, Hirai H.
    Mesenchymal Stem Cells Ameliorate Cerebellar Pathology in a Mouse Model of Spinocerebellar Ataxia Type 1.
    Cerebellum  2014 Jun;13(3):323-30. (IF: 2.595)

  13. Okonogi N, Nakamura K, Suzuki Y. Suto N. Suzue K. Kaminama T. Nakano T. Hirai H.
    Cranial irradiation induces bone marrow-derived microglia in adult mouse brain tissue.
    Journal of Radiation Research　2014 Apr 4. [Epub ahead of print] (IF: 1.447)

  14. Uesaka N, Uchigashima M, Mikuni T, Nakazawa T, Nakao H, Hirai H, Aiba A, Watanabe M, Kano M.
    Retrograde semaphorin signaling regulates synapse elimination in the developing mouse brain.
    Science 2014 May 30;344(6187):1020-3. (IF: 31.03)

病態病理学分野

  1. Pierscianek D, Kim YH, Motomura K, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Wrede K, Nakazato Y, Tanaka Y, Mariani L, Vital A, Sure U, Ohgaki H.
    MET gain in diffuse astrocytomas is associated with poorer outcome.
    Brain Pathol, 23: 13-18, 2013. (IF:4.739)
  2. Motomura K, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nakazato Y, Tanaka Y, Nonoguchi N, Pierscianek D, Kim YH, Mariani L, Vital A, Perry A, Ohgaki H.
    PDGFRA gain in low-grade diffuse gliomas.
    J Neuropathol Exp Neurol, 72: 61-66, 2013. (IF:4.345)
  3. Oike T, Suzuki Y, Sugawara K, Shirai K, Noda SE, Tamaki T, Nagaishi M, Yokoo H, Nakazato Y, Nakano T.
    Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results.
    PLoS One, 8: e78943, 2013. (IF:3.730)
  4. Muragaki Y, Akimoto J, Maruyama T, Iseki H, Ikuta S, Nitta M, Maebayashi K, Saito T, Okada Y, Kaneko S, Matsumura A, Kuroiwa T, Karasawa K, Nakazato Y, Kayama T.
    Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors.
    J Neurosurg, 119: 845-852, 2013. (IF=3.148)
  5. Shibui S, Narita Y, Mizusawa J, Beppu T, Ogasawara K, Sawamura Y, Kobayashi H, Nishikawa R, Mishima K, Muragaki Y, Maruyama T, Kuratsu J, Nakamura H, Kochi M, Minamida Y, Yamaki T, Kumabe T, Tominaga T, Kayama T, Sakurada K, Nagane M, Kobayashi K, Nakamura H, Ito T, Yazaki T, Sasaki H, Tanaka K, Takahashi H, Asai A, Todo T, Wakabayashi T, Takahashi J, Takano S, Fujimaki T, Sumi M, Miyakita Y, Nakazato Y, Sato A, Fukuda H, Nomura K.
    Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).
    Cancer Chemother Pharmacol, 71: 511-521, 2013. (IF:2.795)
  6. Takechi Y, Mieda T, Iizuka A, Toya S, Suto N, Takagishi K, Nakazato Y, Nakamura K, Hirai H.
    Impairment of spinal motor neurons in spinocerebellar ataxia type 1-knock-in mice.
    Neurosci Lett, 535: 67-72, 2013. (IF:2.026)
  7. Matsumura N, Yokoo H, Ying M, Wang Y, Nakazato Y.
    Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters – the implication of a common progenitor cell?
    Neuropathology 33: 246-255, 2013. (IF:1.909)
  8. Nagaishi M, Yokoo H, Osawa T, Nobusawa S, Tanaka Y, Ikota H, Yoshimoto Y, Nakazato Y.
    Cytoplasmic iron deposition is associated with the expression of oxidative DNA damage marker in meningiomas.
    Neuropathology, 33: 526-532, 2013. (IF:1.909)
  9. Sasaki A, Yokoo H, Tanaka Y, Homma T, Nakazato Y, Ohgaki H.
    Characterization of microglia/macrophages in gliomas developed in S100β-v-erbB transgenic rats.
    Neuropathology, 33: 505-514, 2013. (IF:1.909)
  10. Takahashi S, Hiromura K, Tsukida M, Ohishi Y, Hamatani H, Sakurai N, Sakairi T, Ikeuchi H, Kaneko Y, Maeshima A, Kuroiwa T, Yokoo H, Aoki T, Nagata M, Nojima Y.
    Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency.
    J Am Soc Nephrol, 24: 1305-1312, 2013. (IF:8.987)
  11. Nobusawa S, Suzuki A, Nagaishi M, Isoda K, Ikota H, Yokoo H, Hirato J, Nakazato Y.
    Anaplastic ependymoma with ependymoblastic multilayered rosettes.
    Hum Pathol, 44: 2597-2602, 2013. (IF:2.843)
  12. Hirose T, Nobusawa S, Nakazato Y, Sasaki A.
    A case of oligodendroglioma with prominent neuronal differentiation.
    Hum Pathol, 44: 2353-2359, 2013. (IF:2.843)
  13. Fu YJ, Taniguchi Y, Takeuchi S, Shiga A, Okamoto K, Hirato J, Nobusawa S, Nakazato Y, Kakita A, Takahashi H.
    Cerebral astroblastoma in an adult: An immunohistochemical, ultrastructural and genetic study.
    Neuropathology, 33: 312-319, 2013. (IF:1.909)
  14. Ishida A, Shibuya M, Komori T, Nobusawa S, Niimura K, Matsuo S, Hori T.
    Papillary tumor of the pineal region: a case involving isocitrate dehydrogenase (IDH) genotyping.
    Brain Tumor Pathol 30: 45-49, 2013. (IF=1.583)
  15. Shintaku M, Yoneda H, Hirato J, Nagaishi M, Okabe H.
    Gliosarcoma with ependymal and PNET-like differentiation.
    Clin Neuropathol. 2013 Nov-Dec;32(6):508-514. (IF=1.341)
  16. Hamada T, Kakizaki S, Koiso H, Irisawa H, Nobusawa S, Mori M.
    Primary hepatic mucosa-associated lymphoid tissue (MALT) lymphoma.
    Clinical Journal of Gastroenterology, 6(2): 150-155, 2013. (IF=?)
  17. Ohyama Y, Tsuchiya H, Kurosawa K, Nakano A, Arai M, Nobusawa S, Nakazato Y, Kurabayashi M.
    Pulmonary hypertension with extensive calcification in small pulmonary vessels and alveolar capillary wall in a chronic hemodialysis patient.
    Journal of Cardiology Cases, 8: e13-e16, 2013. (IF=?)

脳神経内科学分野

  1. Hayashi S, Amari M, and Okamoto K:
    Loss of calretinin- and parvalbumin-immunoreactive axons in anterolateral columns beyond the corticospinal tracts of amyotrophic lateral sclerosis spinal cords.
    J Neurol Sci., 331: 61-66, 2013. (IF: 2.243)
  2. Sakurai A, Makioka K, Fukuda T, Takatama M, and Okamoto K.
    Accumulation of phosphorylated TDP-43 in the CNS of a patient with Cockayne syndrome.
    Neuropathology., 33: 673-677, 2013. (IF: 1.909)
  3. Furuta N, Makioka K, Fujita Y, Ikeda M, Takatama M, Matsuoka M, and Okamoto K.
    Reduced expression of BTBD10 in anterior horn cells with Golgi fragmentation and pTDP-43-positive inclusions in patients with sporadic amyotrophic lateral sclerosis.
    Neuropathology., 33: 397-404, 2013. (IF: 1.909)
  4. Liu W, Yamashita T, Tian F, Morimoto N, Ikeda Y, Deguchi K, and Abe K.
    Mitochondrial fusion and fission proteins expression dynamically change in a murine model of amyotrophic lateral sclerosis.
    Curr Neurovasc Res., 10: 222-230, 2013. (IF: 2.844)
  5. Miyazaki K, Yamashita T, Morimoto N, Sato K, Mimoto T, Kurata T, Ikeda Y, and Abe K.
    Early and selective reduction of NOP56 (Asidan) and RNA processing proteins in the motor neuron of ALS model mice.
    Neurol Res., 35: 744-754, 2013. (IF: 1.182)
  6. Kurata T, Miyazaki K, Morimoto N, Kawai H, Ohta Y, Ikeda Y, and Abe K.
    Atorvastatin and pitavastatin reduce oxidative stress and improve IR/LDL-R signals in Alzheimer’s disease.
    Neurol Res., 35: 193-205, 2013. (IF: 1.182)
  7. Sato K, Morimoto N, Kurata T, Mimoto T, Miyazaki K, Ikeda Y, and Abe K.
    Impaired hypoxic sensor Siah-1, PHD3, and FIH system in spinal motor neurons of an amyotrophic lateral sclerosis mouse model.
    J Neurosci Res., 91: 285-291, 2013. (IF: 2.974)
  8. Furuta N, Makioka K, Fujita Y, and Okamoto K.
    Changes in the clinical features of amyotrophic lateral sclerosis in rural Japan.
    Intern Med., 52: 1691-1696, 2013. (IF: 0.973)
  9. Ikeda M, Yonemura K, Kakuda S, Tashiro Y, Fujita Y, Takai E, Hashimoto Y, Makioka K, Furuta N, Ishiguro K, Maruki R, Yoshida J, Miyaguchi O, Tsukie T, Kuwano R, Yamazaki T, Yamaguchi H, Amari M, Takatama M, Harigaya Y, and Okamoto K.
    Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer’s disease with PS1 mutations.
    Amyloid., 20: 107-112, 2013. (IF: 4.436)
  10. Sohmiya M, Wada N, Tazawa M, Okamoto K, and Shirakura K.
    Immediate effects of physical therapy on gait disturbance and frontal assessment battery in Parkinson’s disease.
    Geriatr Gerontol Int., 13: 630-637, 2013. (IF: 2.167)
  11. Matsuzono K, Yoshiki T, Wakutani Y, Manabe Y, Yamashita T, Deguchi K, Ikeda Y, and Abe K.
    Synchronized Babinski and Chaddock signs preceded the MRI findings in a case of repetitive transient ischemic attack.
    Intern Med., 52: 2127-2129, 2013. (IF: 0.973)
  12. Matsuzono K, Ikeda Y, Deguchi S, Yamashita T, Kurata T, Deguchi K, and Abe K.
    Cerebral embolic stroke after disappearing takotsubo cardiomyopathy.
    J Stroke Cerebrovasc Dis., 22: e682-683, 2013. (IF: 1.984)
  13. Matsuzono K, Kurata T, Deguchi S, Yamashita T, Deguchi K, Ikeda Y, and Abe K.
    Two Unique Cases with Anti-GluR Antibody-Positive Encephalitis.
    Clin Med Insights Case Rep., 23: 113-117, 2013. (IF:無し)
  14. Matsuzono K, Ikeda Y, Liu W, Kurata T, Deguchi S, Deguchi K, and Abe K.
    A novel familial prion disease causing pan-autonomic-sensory neuropathy and cognitive impairment.
    Eur J Neurol., 20: e67-69, 2013. (IF: 4.162)
  15. Kono S, Deguchi K, Morimoto N, Kurata T, Yamashita T, Ikeda Y, Narai H, Manabe Y, Takao Y, Kawada S, Kashihara K, Takehisa Y, Inoue S, Kiriyama H, and Abe K.
    Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    J Stroke Cerebrovasc Dis., 22: 1175-1183, 2013. (IF: 1.984)
  16. Deguchi K, Kono S, Deguchi S, Morimoto N, Kurata T, Ikeda Y, and Abe K.
    A novel useful tool of computerized touch panel-type screening test for evaluating cognitive function of chronic ischemic stroke patients.
    J Stroke Cerebrovasc Dis., 22: e197-206, 2013. (IF: 1.984)
  17. Morimoto N, Yamashita T, Sato K, Kurata T, Ikeda Y, Kusuhara T, Murata N, and Abe K.
    Assessment of swallowing in motor neuron disease and Asidan/SCA36 patients with new methods.
    J Neurol Sci., 324: 149-155, 2013. (IF: 2.243)
  18. Ikeda Y, Ohta Y, Kurata T, Shiro Y, Takao Y, and Abe K.
    Acoustic impairment is a distinguishable clinical feature of Asidan/SCA36.
    J Neurol Sci., 324: 109-112, 2013. (IF: 2.243)

脳神経外科学分野

  1. Osawa T, Tosaka M, Nagaishi M,Yoshimoto Y.
    Factors Affecting Peritumoral Brain Edema in Meningioma: Special Histological Subtypes with Prominently Extensive Edema
    J Neurooncol, 2013; 111: 49-57. [IF 3.115]
  2. Nagaishi M, Yokoo H, Osawa T, Nobusawa S, Tanaka Y, Ikota H, Yoshimoto Y, Nakazato Y.
    Cytoplasmic iron deposition is associated with the expression of oxidative DNA damage marker in meningiomas.
    Neuropathology. 2013 Oct; 33(5):526-32. [IF 1.909]
  3. Aishima K, Yoshimoto Y.
    Screening Strategy Using Sequential Serum D-Dimer Assay for the Detection and Prevention of Venous Thromboembolism after Elective Brain Tumor Surgery
    Br J Neurosurg, 2013; 27: 348-54. [IF 0.858]
  4. Iijima K, Horiguchi K, Yoshimoto Y.
    Microvascular Decompression of the Root Emerging Zone for Hemifacial Spasm: Evaluation by Fusion Magnetic Resonance Imaging and Technical Considerations
    Acta Neurochir (Wien), 2013; 155: 855-62. [IF 1.546]
  5. Shimizu M, Imai H, Kagoshima K, Umezawa E, Shimizu T,　Yoshimoto Y.
    Detection of Compression Vessels in Trigeminal Neuralgia by Surface-Rendering Three-Dimensional Reconstruction of 1.5- and 3.0-T Magnetic Resonance Imaging
    World Neurosurg, 2013; 80: 378-85. [IF 1.765]
  6. Tosaka M, Sakamoto K, Watanabe S, Yodonawa M, Kunimine H, Aishima K, Fujii T, Yoshimoto Y.
    Critical Classification of Craniostomy for Chronic Subdural Hematoma; Safer Technique for Hematoma Aspiration
    Neurol Med Chir (Tokyo), 2013 ; 53 :273-8.[ [IF 0.504]
  7. Yoshimoto Y, Tanaka Y.
    Risk Perception of Unruptured Intracranial Aneurysms
    Acta Neurochir (Wien), 2013;155 :2029-36. [IF 1.546]
  8. Ono H, Nakatomi H, Tsutsumi K, Inoue T, Teraoka A, Yoshimoto Y, Ide T, Kitanaka C, Ueki K, Imai H, Saito N.
    Symptomatic recurrence of intracranial arterial dissections: follow-up study of 143 consecutive cases and pathological investigation.
    Stroke 2013; 44: 126-31. [IF 6.158]

眼科学分野

  1. Otani T, Yamaguchi Y, Kishi S.
    Movement of intraretinal fluid from distant branch retinal vein occlusion to the submacular space. Clin Ophthalmol. 2013;7:81-6. (IF:0)
  2. Itakura H, Kishi S.
    Alterations of posterior precortical vitreous pockets with positional changes. Retina. 2013 Jul-Aug;33(7):1417-20. (IF:2.81)
  3. Itakura H, Kishi S, Li D, Akiyama H.
    Observation of posterior precortical vitreous pocket using swept-source optical coherence tomography. Invest Ophthalmol Vis Sci. 2013 May 3;54(5):3102-7. (IF:3.59)
  4. Itakura H, Kishi S.
    Evolution of vitreomacular detachment in healthy subjects. JAMA Ophthalmol. 2013 Oct;131(10):1348-52(IF:3.71)
  5. Akiyama H, Kashima T, Li D, Shimoda Y, Mukai R, Kishi S.
    Retinal ganglion cell analysis in Leber’s hereditary optic neuropathy Ophthalmology. 2013 Sep;120(9):1943-4 (IF:5.45)
  6. Sato T, Kishi S, Matsumoto H, Mukai R.
    Comparisons of outcomes with different intervals between adjunctive ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol. 2013 Jul;156(1):95-105. (IF:4.22)
  7. Sato T, Kishi S, Otani T, Hashimoto H, Watanabe G.
    Modified technique for inducing posterior vitreous detachment through the posterior precortical vitreous pocket during microincision vitreous surgery with a wide-angle viewing system. Ophthalmologica. 2013;230(2):76-80. (IF:1.42)
  8. Itakura H, Kashima T, Itakura M, Akiyama H, Kishi S.
    Topical rebamipide improves lid wiper epitheliopathy. Clin Ophthalmol. 2013;7:2137-41. (IF:0)
  9. Shinohara Y, Kashima T, Akiyama H, Kishi S.
    Alteration of choroidal thickness in a case of carotid cavernous fistula: a case report and a review of the literature. SBMC Ophthalmol. 2013 Dec 5;13:75. (IF:1.44)

PAGETOP